Literature DB >> 9836114

Observer agreement in endoscopic assessment of ulcerative colitis.

F Orlandi1, E Brunelli, G Feliciangeli, G Svegliati-Baroni, A Di Sario, A Benedetti, C Guidarelli, G Macarri.   

Abstract

BACKGROUND: Colonoscopy is the investigation of choice to evaluate ulcerative colitis, but the reliability of the assessment of endoscopic signs is not clear. AIMS: The aim of this study was to evaluate interobserver agreement for the identification of endoscopic lesions typical of ulcerative colitis, and the influence of training.
MATERIAL AND METHODS: Four experienced observers and 11 endoscopists under training assessed 49 still images selected from endoscopic video recordings.
RESULTS: The agreement rate between experienced observers was excellent or good (k > 0.39) for recognition of 10 out of 14 signs or patterns (loss of vascular pattern, erythema, oedema, granular mucosa, blood, pseudopolyp, erosion, ulcer, normal pattern, severe activity), and was poor for pus, stricture, mild activity, moderate activity. The rates between endoscopists under training were excellent or good for 6 items (loss of vascular pattern, erythema, oedema, pseudopolyp, normal pattern, severe activity).
CONCLUSIONS: Trained observers can reproducibly record most endoscopic signs of ulcerative colitis. A reliable overall scoring of severity should be based on a simple three-grading scale, i.e. normal pattern, moderate activity, severe activity. Acceptable agreement rates can be obtained by endoscopists under training on some well-defined endoscopic appearances.

Entities:  

Mesh:

Year:  1998        PMID: 9836114

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  8 in total

1.  A critical review of endoscopic indices in ulcerative colitis: inter-observer variation of the endoscopic index.

Authors:  Fumihito Hirai; Toshiyuki Matsui
Journal:  Clin J Gastroenterol       Date:  2008-06-27

2.  Do You See What I See? An Assessment of Endoscopic Lesions Recognition and Description by Gastroenterology Trainees and Staff Physicians.

Authors:  Lara Hart; Mallory Chavannes; Peter L Lakatos; Waqqas Afif; Alain Bitton; Brian Bressler; Talat Bessissow
Journal:  J Can Assoc Gastroenterol       Date:  2019-06-19

Review 3.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

4.  Limitations in assessment of mucosal healing in inflammatory bowel disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

5.  Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).

Authors:  Simon P L Travis; Dan Schnell; Piotr Krzeski; Maria T Abreu; Douglas G Altman; Jean-Frédéric Colombel; Brian G Feagan; Stephen B Hanauer; Marc Lémann; Gary R Lichtenstein; Phillippe R Marteau; Walter Reinisch; Bruce E Sands; Bruce R Yacyshyn; Christian A Bernhardt; Jean-Yves Mary; William J Sandborn
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

6.  Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis.

Authors:  Thomas de Lange; Stig Larsen; Lars Aabakken
Journal:  BMC Gastroenterol       Date:  2004-05-18       Impact factor: 3.067

7.  Endoscopic assessment of the duodenum in dogs with inflammatory bowel disease.

Authors:  J E Slovak; C Wang; J A Morrison; K L Deitz; D N LeVine; C Otoni; R R King; L E Gerber; K R Hanson; A P Lundberg; A E Jergens
Journal:  J Vet Intern Med       Date:  2014 Sep-Oct       Impact factor: 3.333

8.  The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

Authors:  Simon P L Travis; Dan Schnell; Brian G Feagan; Maria T Abreu; Douglas G Altman; Stephen B Hanauer; Piotr Krzeski; Gary R Lichtenstein; Philippe R Marteau; Jean-Yves Mary; Walter Reinisch; Bruce E Sands; Patrick Schnell; Bruce R Yacyshyn; Jean-Frédéric Colombel; Christian A Bernhardt; William J Sandborn
Journal:  J Crohns Colitis       Date:  2015-05-08       Impact factor: 9.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.